AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 34 filers reported holding AMRYT PHARMA PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,139,400 | -18.9% | 978,000 | -23.1% | 0.12% | -18.3% |
| Q3 2022 | $8,802,000 | +6.9% | 1,272,000 | +8.0% | 0.15% | +6.2% |
| Q2 2022 | $8,234,000 | -0.4% | 1,178,000 | +17.8% | 0.14% | -10.0% |
| Q1 2022 | $8,270,000 | -4.3% | 1,000,000 | +25.0% | 0.16% | +13.5% |
| Q4 2021 | $8,640,000 | +15.0% | 800,000 | +28.2% | 0.14% | +11.0% |
| Q3 2021 | $7,516,000 | +84.4% | 624,000 | +85.7% | 0.13% | +74.0% |
| Q2 2021 | $4,076,000 | +46.3% | 336,000 | +68.0% | 0.07% | +14.1% |
| Q1 2021 | $2,786,000 | -1.6% | 200,000 | 0.0% | 0.06% | -33.3% |
| Q4 2020 | $2,832,000 | -25.1% | 200,000 | -34.6% | 0.10% | -29.9% |
| Q3 2020 | $3,782,000 | – | 306,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |